A Study of TYRA-300 in Children With Achondroplasia: BEACH301
Trial details
- Registry ID
- NCT06842355
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of TYRA-300 in Children With Achondroplasia: BEACH301NCT06842355 | TYRA | Phase 2 | Recruiting | 2030-01Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |